Abdi Ibrahim, a Turkish pharmaceutical company has selected rfxcel to implement and support new compliance management and serialisation processing software to ensure full compliance with current and future international legislative requirements ahead of the 2019 EU Falsified Medicines Directive (FMD) deadline.
With the February 2019 FMD deadline fast approaching, Abdi Ibrahim needed a solutions provider that would enable it to become compliant in time for the FMD deadline, but additionally would fulfil its need for modern technological operations with data integrity at its core.
Adbi Ibrahim selected rfxcel due to the solution’s rich functionality as well as the company’s single tenant private cloud deployment, its full-service implementation methodology, flexibility and speed and competitive pricing.
Rumeysa Tanrikulu, Information Systems Supervisor at Abdi Ibrahim explained: “It was really important for us to implement a software solution that was single-tenant rather than multi-tenant. rfxcel was one of the only single tenant providers that offered a bespoke service at a reasonable cost. What’s more, the team at rfxcel was direct, clear and extremely helpful, answering all the questions we threw at them.”
She addsed: “The team was friendly and driven not by the sale, but by the benefit they could bring to the business. For us, given the weight of responsibility we feel we carry in improving the health of the population we serve, their company ethos was very much aligned to ours. So far, our relationship has been honest, collaborative and we have full visibility of the implementation process that will help ensure not only regulatory compliance, but a future-proof supply chain that is built upon the foundation of data quality.”
Adbi Ibrahim is currently mid-implementation with aims for the compliance management and serialisation processing software to be live during October 2018.
